Delivery Order SPE2DB22D2007-SPE2DB24FJ3UM

Award Date 6/28/24
Potential Completion Date 7/1/24
Potential Value $5.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The award, valued at $19,205.87, is for the delivery of 4,564,881,167 units of Concerta ER 36 mg tablets. The contract is a firm fixed-price delivery order with a completion date of June 12, 2024. Amerisourcebergen holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Concerta ER 27 mg tablets. The contract, valued at $6,832.56, is a firm-fixed price delivery order with a completion date of July 9, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, for the delivery of Concerta ER 36 mg tablets. The award is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies to DLA facilities...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, for the provision of Concerta ER 27 mg tablets. The contract is a delivery order valued at $1,818.74, with a completion date of May 17, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025, which serves as the...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Concerta ER 36 mg tablets. The contract, valued at $11,838.11, is a delivery order contract with a firm fixed price. The ultimate completion date is July 31, 2024, and there is no set-aside designation. This award is likely part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor, for the delivery of Concerta ER 27 mg tablets. The contract has a total ceiling value of $6,427.55 and is a delivery order under an Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical valued up to $999,999,999.00 through December 2025. This larger IDC serves as the primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,715.92 firm fixed-price delivery order contract is for the supply of CONCERTA ER 36 MG TABLET 100S, a pharmaceutical product. The contract has an ultimate completion date of March 17, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, provides for the delivery of Concerta ER 36mg tablets. The $37,092.45 firm-fixed-price delivery order was issued by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the U.S. Department of Defense. The contract has a period of performance through November 1, 2024 and does not utilize a set-aside designation, indicating open competition. Amerisourcebergen holds a $999,999,999...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of CONCERTA ER 36 MG TABLET 100S. The fixed-price delivery order is valued at $14,910.43 and has a completion date of September 26, 2024. Amerisourcebergen holds a broader Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999, to supply a comprehensive range of medical commodities to support...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $44,105.94 firm-fixed-price delivery order is for the supply of Concerta ER Tablets (27 mg) through November 27, 2024. This award is associated with AmerisourceBergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which covers a comprehensive range of pharmaceutical products and medical...
  • SPE2DB22D2007
    Indefinite Delivery Contract
  • SPE2DB22D2007-SPE2DB24FJ3UM
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Concerta ER 36 mg tablets. The $5,177.09 firm-fixed price delivery order has a completion date of July 1, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 2025, which serves as the primary vehicle for the company to supply a wide range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. This contract does not have a set-aside designation.

Generated 9/27/24, 9:22 AM